Jürgen Muser

521 total citations
11 papers, 402 citations indexed

About

Jürgen Muser is a scholar working on Infectious Diseases, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Jürgen Muser has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Pathology and Forensic Medicine and 2 papers in Surgery. Recurrent topics in Jürgen Muser's work include Vitamin D Research Studies (3 papers), COVID-19 Clinical Research Studies (3 papers) and Vitamin C and Antioxidants Research (2 papers). Jürgen Muser is often cited by papers focused on Vitamin D Research Studies (3 papers), COVID-19 Clinical Research Studies (3 papers) and Vitamin C and Antioxidants Research (2 papers). Jürgen Muser collaborates with scholars based in Switzerland, Germany and United States. Jürgen Muser's co-authors include Reto Krapf, Henry N. Hulter, Kaspar Berneis, Sigrid Jehle, André R. Miserez, Christina Jeanneret, Susanne Schenk, Ruth Chiquet‐Ehrismann, Rolf Handschin and Hans‐Peter Brunner‐La Rocca and has published in prestigious journals such as Journal of the American Society of Nephrology, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Cancer.

In The Last Decade

Jürgen Muser

11 papers receiving 382 citations

Peers

Jürgen Muser

NEPHR

CCM

EDM

SURGE

Claudia Fofi Italy

Jinshan Wu China

Bjarne Myrup Denmark

Nagwa Mohamed Egypt

Katherine Fredrich United States

Jiri Frohlich Canada

Shiwori Osada Japan

Montserrat Baldán‐Martín Spain

George Dragicevic Australia

Beata Marie Redublo Quinto Brazil

Claudia Fofi Italy

Jürgen Muser

209 ×2.2

NEPHR

76 ×0.8

CCM

46 ×0.5

EDM

61 ×0.8

SURGE

98 ×1.4

Citations per year, relative to Jürgen Muser Jürgen Muser (= 1×) peers Claudia Fofi

Countries citing papers authored by Jürgen Muser

Since Specialization

Citations

This map shows the geographic impact of Jürgen Muser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Muser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Muser more than expected).

Fields of papers citing papers by Jürgen Muser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Muser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Muser. The network helps show where Jürgen Muser may publish in the future.

Co-authorship network of co-authors of Jürgen Muser

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Muser. A scholar is included among the top collaborators of Jürgen Muser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Muser. Jürgen Muser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Giezendanner, Stéphanie, et al.. (2023). Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study. Journal of Clinical Medicine. 12(17). 5520–5520. 1 indexed citations

Giezendanner, Stéphanie, Philippe Haas, Anne Leuppi-Taegtmeyer, et al.. (2023). Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay. Biomedicines. 11(5). 1277–1277. 8 indexed citations

Haas, Philippe, Philipp Schüetz, Luca Gabutti, et al.. (2022). High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study—VitCov Trial. Trials. 23(1). 114–114. 15 indexed citations

Giezendanner, Stéphanie, Michael Brändle, Thomas Dieterle, et al.. (2021). Multilabel classification of disease prediction in patients presenting with dyspnea. PA3447–PA3447. 1 indexed citations

Labhardt, Niklaus Daniel, Karolin Pfeiffer, Thabo Ishmael Lejone, et al.. (2014). Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART‐1 study. Journal of the International AIDS Society. 17(4S3). 19552–19552. 4 indexed citations

Hulter, Henry N., et al.. (2012). Role of endothelin-1 in renal regulation of acid-base equilibrium in acidotic humans. American Journal of Physiology-Renal Physiology. 303(7). F991–F999. 8 indexed citations

Kiencke, Stephanie, Rolf Handschin, Jürgen Muser, et al.. (2010). Pre-Clinical Diabetic Cardiomyopathy: Prevalence, Screening, and Outcome. European Journal of Heart Failure. 12(9). 951–957. 90 indexed citations

Jehle, Sigrid, et al.. (2006). Partial Neutralization of the Acidogenic Western Diet with Potassium Citrate Increases Bone Mass in Postmenopausal Women with Osteopenia. Journal of the American Society of Nephrology. 17(11). 3213–3222. 126 indexed citations

Berneis, Kaspar, et al.. (2005). Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism. 54(2). 227–234. 76 indexed citations

10.

Ballmoos, Moritz Wyler von, et al.. (2005). Increased Apolipoprotein Deposits in Early Atherosclerotic Lesions Distinguish Symptomatic From Asymptomatic Patients. Arteriosclerosis Thrombosis and Vascular Biology. 26(2). 359–364. 14 indexed citations

11.

Schenk, Susanne, et al.. (1995). Tenascin‐C in serum: A questionable tumor marker. International Journal of Cancer. 61(4). 443–449. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact